The case study below demonstrates how implementing effective safety netting, including the use of e-safety netting tools, at key touchpoints in the primary care pathway can support timelier diagnosis.

Safety-netting tools are electronic systems designed to improve the tracking and follow-up of patients who may be at risk of cancer.

Cheltenham Fundraising Group for Cancer Research UK Dedicated to making a difference. About Us The Cheltenham Fundraising Group is a passionate collective of individuals committed to supporting Cancer ...

You might have stereotactic ablative radiotherapy to treat liver cancer. Stereotactic ablative radiotherapy (SABR) gives radiotherapy from many different angles around the body. The beams meet at the ...

This study is asking people about their experiences of having radiotherapy for prostate or breast cancer. It is also asking them about their travel to hospital to find out about the impact of ...

Capecitabine and temozolomide (CAPTEM) are chemotherapy drugs. This combination is a treatment for neuroendocrine tumours.

Remote consultations have become more commonplace in primary care since the COVID-19 pandemic. They present multiple challenges, as well as benefits, for health professionals and patients to navigate.

Ampullary cancer is a rare type of cancer of the ampulla. This is where the bile duct and pancreatic duct join the small bowel. Surgery and chemotherapy are the main treatments for ampullary cancer.

Pancreatic neuroendocrine cancers are rare cancers that start in the neuroendocrine cells of the pancreas. There are many different types.

Grades and stages of neuroendocrine cancer The tests and scans you have give information about the stage and grade of your cancer. A specialist doctor (pathologist ) looks at the cancer cells under a ...

This trial is comparing proton beam therapy with intensity modulated radiotherapy to treat cancer of the nose and sinuses.

We want to support the research that will make a real difference to people with brain tumours. To achieve our ambitions for brain tumour research, we are: Spending around £25 million over the next ...